Wine and the heart;Vino y corazón

Revista Espanola de Cardiologia

Volumn 51, Issue 6, 1998, Pages 435-449

  Rayo Llerena, Isabel ^a   Marín Huerta, Emilio ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIOXIDANT; LIPID;

ALCOHOLIC BEVERAGE; BLOOD; CORONARY ARTERY DISEASE; DRINKING BEHAVIOR; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; REVIEW; RISK ASSESSMENT; THROMBOCYTE AGGREGATION; WINE;

ALCOHOL DRINKING; ALCOHOLIC BEVERAGES; ANTIOXIDANTS; CORONARY DISEASE; ETHANOL; FEMALE; HUMANS; LIPIDS; MALE; PLATELET AGGREGATION; RISK ASSESSMENT; WINE;

EID: 0032086523     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(98)74772-4     Document Type: Review

References (161)

1. Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ 1994; 309: 911-918.
2. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I et al. Alcohol consumption and mortality among women. N Engl J Med 1995; 332: 1.245-1.250.
3. Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study Epidemiology 1990; 1: 342-348.
4. Camargo CA Jr. Moderate alcohol consumption and stroke: the epidemiological evidence. Stroke 1989; 20: 1.611-1.626.
5. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med 1992; 117: 646-654.
6. Blackwelder WC, Yano K, Rhoads GG, Kagan A, Gordon T, Palesch Y. Alcohol and mortality: the Honolulu Heart Study. Am J Med 1980; 68: 164-169.
7. Usehima H, Ohsaka T, Asakura S. Regional differences in stroke mortality and alcohol consumption in Japan. Stroke 1986; 17: 19-24.
8. Moore RD, Pearson TA. Moderate alcohol consumption and coronary artery disease. A review. Medicine 1986; 65: 242-267.
9. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev 1993; 5: 328-335.
10. Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979; 1: 1.017-1.020.
11. LaPorte RE, Cresanta JL, Kuller LH. The relationship of alcohol consumption to atherosclerotic heart disease [revisión]. Prev Med 1980; 9: 22-40.
12. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? BMJ 1996; 312: 731-736.
13. Pohorecky LA. Interaction of alcohol and stress at the cardiovascular level. Alcohol 1990; 7: 537.
14. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDerburgh M et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993; 329: 1.829-1.834.
15. Steinberg D. Alcohol and atheroesclerosis. Ann Intern Med 1991; 114: 967-976.
16. Schmidt W, Popham RE. Alcohol consumption and ischemic heart disease: some evidence from population studies. Br J Addict 1981; 76: 407-417.
17. Nanji AA. Alcohol and ischemic heart disease: wine, beer or both? Int J Cardiol 1985; 8: 487-489.
18. Nanji AA, French SW. Alcoholic beverages and coronary heart disease. Atherosclerosis 1986; 60: 197-198.
19. Hegsted DM, Ausman LM. Diet, alcohol and coronary heart disease in men. J Nutr 1988; 118: 1.184-1.189.
20. Artaud-Wild SM, Connor SL, Sexton G, Connor WE. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Filand-a paradox. Circulation 1993; 88: 2.771-2.779.
21. Hennekens CH, Willett W, Rosner B, Cole DS, Mayrent SL. Effects of beer, wine, and liquor in coronary deaths. JAMA 1979; 242: 1.973-1.974.
22. Rosenberg L, Slone D, Shapiro S, Kaufman DW, Miettinen OS, Stolley PD. Alcoholic beverages and myocardial infarction in young women. Am J Public Health 1981; 71: 82-85.
23. Kaufman DW, Rosenberg L, Helmnch SP, Shapiro S. Alcoholic beverages and myocardial infarction in young men. Am J Epidemiol 1985; 121: 548-554.
24. Yano K, Rhoads A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med 1977; 297: 405-409.
25. Kagan A, Yano K, Rhoads GG, McGee DL. Alcohol and cardivascular disease: the Hawaiian experience. Circulation 1981; 64 (Supl 3): 27-31.
26. Kozarevic D, McGee D, Vojvodic N, Racic Z, Dawber T, Gordon T et al. Frequency of alcohol consumption and morbidity and mortality: the Yugoslavia cardiovascular disease study. Lancet 1980; 1: 613-616.
27. Salonen JT, Puska P, Nissinen A. Intake of spirits and beer and risk of myocardial infarction and death-a longitudinal study in eastern Finland. J Chron Dis 1983; 36: 533-543.
28. Kittner SJ, Garcia PM, Costas RJ, Cruz VM, Abbott RD, Havlik RJ. Alcohol and coronary heart disease in Puerto Rico. Am J Epidemiol 1983; 117: 538-550.
29. Friedman LA, Kimbali AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 1986; 124: 481-489.
30. Stampfer MJ, Colditz GA, Willen WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of cororary disease and stroke in women. N Engl J Med 1988; 319: 267-273.
31. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B et al Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464-468.
32. Farchi G, Fidanza F, Mariotti S, Menotti A. Alcohol and mortality in the Italian rural cohorts of the seven countries study. Int J Epidemiol 1992; 21: 74-81.
33. Klatsky AL, Armstrong MA, Friedman GD. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol 1990; 66: 1.237-1.242.
34. Klatsky AL, Armstrong MA, Friedman GD. Relation of alcohol beverage use to subsequent coronary artery disease hospitalization. Am J Cardiol 1986; 58: 710-714.
35. Gronback M, Deis A, Sorensen TA, Becker U, Schohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. Br Med J 1995; 310: 1.165-1.169.
36. Doll R, Peto R, Hall E, Wheatley K, Gray R. Alcohol and coronary heart disease reduction among british doctors: confounding or causality? Eur Heart J 1997; 18: 23-25.
37. Rayo I, Marín Huerta E. Intervenciones farmacológicas sobre la progresión de la ateroesclerosis coronaria. Rev Esp Cardiol 1995; 48: 341-358.
38. Marín Huerta E, Rayo I. Farmacología cardiovascular en los 90: ¿dónde estamos? Rev Esp Cardiol 1994; 47: 390-402.
39. Koskinen P, Kupari M, Leinonen H. Role of alcohol in recurrences of atrial fibrillation in persons less than 65 years of age. Am J Cardiol 1990; 66: 954-958.
40. Panos RJ, Sutton FJ, Young-Hyman P, Peters R. Sudden death associated with alcohol consumption. Pace 1988; 11: 423-424.
41. Moushmoush B, Abi-Mansour P. Alcohol and the heart. The long term effects of alcohol on the cardiovascular system. Arch Intern Med 1991; 151: 36-42.
42. Vikhert A, Tsiplenkova VG, Cherpachencko NM. Alcoholic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 1986; 8 (Supl A): 3-11.
43. Lieber CS. Metabolism and metabolic effects of alcohol. Med Clin North Am 1984; 68: 3-31.
44. Hennekens CH, Rosner B, Cole DS. Daily alcohol consumption and fatal coronary heart disease. Am J Epidemiol 1978; 107: 1.996-2.000.
45. Klatsky AL, Friedman GD, Siegelaub AB. Alcohol consumption before myocardial infarction: results from the Kaiser-Permanente epidemiologic study of myocardial infarction. Ann Intern Med 1974; 81: 294-301.
46. Stason WB, Neff RK, Miettinen OS, Jick H. Alcohol consumption and non-fatal myocardial infarction. Am J Epidemiol 1976; 104: 603-608.
47. Rosenberg L, Slone D, Shapiro S, Kaufman DW, Miettinen OS, Stolley PD. Alcoholic beverages and myocardial infarction in young women. Am J Public Healh 1981; 71: 82-85.
48. Gordon T, Kannel WB. Drinking habits and cardiovascular disease: the Framingham Study. Am Heart J 1983; 105: 667-673.
49. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and lifestyle characterictics. Am J Epidemiol 1984; 119: 653-666.
50. Cullen K, Stenhouse NS, Wearne KL. Alcohol and mortality in the Brusselton study. Int J Epidemiol 1982; 11: 67-70.
51. Colditz GA, Branch LG, Lipnick RJ, Willet WC, Rosner B, Posner B et al. Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am Heart J 1985; 109: 886-889.
52. Dyer AR, Stamler J, Paul O, Lepper MH, Shekelle RB, McKean H et al. Alcohol consumption and 17-year mortality in the Chicago Western Electric Company study. Prev Med 1980; 9: 78-90.
53. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 1986; 124: 481-489.
54. Gordon T, Doyle JT. Drinking and coronary heart disease: the Albany Study. Am Heart J 1985; 110: 331-334.
55. Moore RD, Pearson TA. Moderate alcohol consumption and coronary artery disease: a review. Medicine (Baltimore) 1986; 65: 242-267.
56. Klatsky AL, Friedman GD, Siegelaub AB. Alcohol and mortality: a ten-year Kaiser-Permanente experience. Ann Intern Med 1981; 95: 139-45.
57. Pell S, D'Alonzo CA. A five-year mortality study of alcoholics. J Occup Med 1973; 15: 120-125.
58. Rosengren A, Wilhelmsen L, Wedel H. Separate and combined effects of smoking and alcohol abuse in middle-aged men. Acta Med Scand 1988; 223: 111-118.
59. Thorarinsson AA. Mortality among men alcoholics in Iceland, 1951-74. J Stud Alcohol 1979; 40: 704-718.
60. Deutscher S, Rockette HE, Krishnaswami V. Evaluation of habitual excesive alcohol consumption on myocardial infarction risk in coronary disease patients. Am Heart J 1984; 108: 988-995.
61. Fraser GE, Upsdell M. Alcohol and other discriminants between cases of sudden death and myocardial infarction. Am J Epidemiol 1981; 114: 462-476.
62. Marmot MG, Rose G, Shipley MJ, Thomas BJ. Alcohol and mortality: a U-shaped curve. Lancet 1981; 1: 580.
63. Shaper AG. Alcohol and coronary heart disease. Eur Heart J 1995; 16: 1.760-1.764.
64. Jackson R, Scragg G, Beaglehole R. Alcohol consumption and risk of coronary heart disease. BMJ 1991; 303: 211-215.
65. Kono S, Ikeda M, Tokudome S, Nishizumi M, Kuratsune M. Alcohol and mortality: a cohort study of male Japanese physicians. Int J Epidemiol 1990; 15: 527-532.
66. Goldberg RJ, Burchfield CM, Reed DM, Wergowske G, Chiu D. A prospective study of the health effects of alcohol consumption in middle-aged and elderly men. Circulation 1994; 89: 651-659.
67. Klatsky AL. Alcohol and coronary artery disease. Alcohol Health & Reasearch World 1990; 14: 289-300.
68. Seigneur M, Bonnet J, Dorian B, Benchimol D, Drouillet F, Gouverneur G et al. Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids. J Appl Cardiol 1990; 5: 215-222.
69. Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992; 43: 1-4.
70. Klatsky AL, Armstrong MA, Kipp H. Correlates of alcoholic beverage preference: traits of persons who choose wine, liquor or beer. Br J Addict 1990; 85: 1.279-1.289.
71. Klatsky AL, Armstrong MA. Alcoholic beverage choice and risk of coronary artery disease mortality: do red wine drinkers fare best? Am J Cardiol 1993; 71: 467-469.
72. Lapone RE, Cauley JA. Wine, age, and coronary heart disease [carta]. Lancet 1981; 1: 105.
73. Renaud S, Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339. 1.523-1.526.
74. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox. Lancet 1994; 344: 1.719-1.723.
75. Barnard MJ, Lanter SPK. Wine and coronary heart disease. Lancet 1992; 340: 313-314.
76. Segall JJ. Wine and coronary heart disease. Lancet 1992; 340: 313.
77. Willet WC, Green A, Stamppfer MJ, Speizer FE, Colditz GA, Rosner B et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1.303-1.309.
78. Manson JE, Tosteson H, Redker PM, Satterfield S, O'Connor HP. The primary prevention of myocardial infarction. N Engl J Med 1992; 326: 1.406-1.416.
79. Dunbabin DW, Sandercock PA. Preventing stroke by the modification of risk factors. Stroke 1990; 21 (Supl 4): 36-39.
80. Maclure M. Demonstration of deductive meta-analysis: etanol intake and risk of myocardial infarction. Epidemiol Rev 1993; 15: 328-351.
81. Ducimetiere P, Guize L, Marciniak A, Milon H, Richard J, Rufat P. Arteriographically documented coronary artery disease and alcohol consumption in French men. The CORALI study. Eur Heart J 1993; 14: 727-733.
82. Kannel WB, Dawber TR, Friedman GR. Risk factors in coronary heart disease. Ann Intern Med 1964; 61: 888-899.
83. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins and the risk of coronary heart disease: the Framingham Study. Ann Intern Med 1971; 74: 1-12.
84. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982; 248: 1.465-1.477.
85. The Coronary Drug Project Research Group. Natural history of myocardial infarction in the Coronary Drug Project: long term prognostic importance of serum lipid levels. Am J Cardiol 1978; 42: 489-498.
86. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986; 2: 933-936.
87. Maremberg ME, Risch N, Berkman LF, Floderus B, De Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1.041-1.046.
88. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
89. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986; 8: 488-500.
90. Mitchinson MS, Ball RV. Macrophages and atherogenesis. Lancet 1982; 2: 146-147.
91. Mitchinson MJ, Ball RY, Carpenter KLH, Enright JH. Macrophages and ceroid in human atherosclerosis. Eur Heart J 1990; 11 (Supl E): 116-121.
92. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witzum J. Beyond cholesterol. Modifications of low-density lipoprotein that increases its atherogenicity. N Engl J Med 1989; 320; 915-924.
93. Kovanen PT. Atheroma formation: defective control in the intimal round trip of cholesterol. Eur Heart J 1990; 11 (Supi E): 238-246.
94. Slotte JP. HDL receptors and cholesterol efflux from parenchymal cells. Eur Heart J 1990; 11 (Supl E): 212-217.
95. Davies MJ, Thomas AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J 1985; 53: 363-373.
96. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease. Circulation 1988; 78: 1.157-1.166.
97. Ambrose JA, Tannenbaurn MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 56-62.
98. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990; 82 (Supl 2): 38-46.
99. Ip J, Fuster V, Badimon L, Badimon J, Taubman M, Chesebro J. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1.667-1.687.
100. Rayo I, Marín Huerta E. La fibrinolisis, los anticoagulantes y los antiagregantes en la historia natural del infarto a medio y largo plazo. Rev Lat Cardiol 1997; 18: 2-6.
101. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992; 85: 910-915.
102. Sun I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol: the Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med 1992; 116: 881-887.
103. Glueck CJ, Hogg E, Allen C, Gartside PS. Effects of alcohol ingestion on lipids and lipoproteins in normal men: isocaloric metabolic studies. Am J Clin Nutr 1980; 33: 2.287-2.293.
104. Hagiage M, Marti C, Rigaud D, Senault C, Fumeron F, Apfelbaum M et al. Effect of a moderate alcohol intake on the lipoproteins of normotriglyceridemic obese subjects compared with normoponderal controls. Metabol Clin Exper 1992; 44: 856-861.
105. Hulley SB, Gordon S. Alcohol and high density lipoprotein cholesterol. Causal inference from diverse study designs. Circulation 1981; 64: 57-63.
106. Thornton J, Symes C, Heaton K. Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet 1983; 2: 819-822.
107. Stampfer MJ, Sacks FMM, Salvini S, Willett WC, Hennekens CH. A prospective study cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991; 325: 373-381.
108. Barr DP, Russ EM, Efer HA. Protein-lipid relationships in human plasma. II. In Atherosclerosis and related conditions. Am J Med 1951; 11: 480-493.
109. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975; 1: 16-19.
110. Gordon T, Caselli WP, Hjortland MC, Kannell WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977; 62: 707-714.
111. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective american Studies. Circulation 1989; 79: 8-15.
112. Reed DM, Strong JP, Resch J, Hayashi T. Serum lipids and lipoproteins as predictors of atheroesclerosis. An autopsy study. Arteriosclerosis 1989; 9: 560-564.
113. Badimon JJ, Fuster V, Badimon L. Role of high density lipoproteins in the regression of atheroesclerosis. Circulation 1992; 86 (Supl 3): 86-94.
114. Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RE et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality. results from the Lipid Research Clinics follow-up study. Am J Epidemiol 1987; 126: 629-637.
115. Suh I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group Ann Intern Med 1992; 116: 881-887.
116. Gofman JW, Young W, Tandy R. Ischemic heart disease, atheroesclerosis and longevity. Circulation 1966; 34: 679-697.
117. Ballantyne FC, Clark RS, Simpson HS, Ballantyne D. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism 1982; 31: 433-437.
118. Diehl AK, Fuller JH, Mattock MB, Salter AM, El-Gohari R, Keen H. The relationship of high density lipoprotein subfractions to alcohol consumption, other lifestyle factors, and coronary heart disease. Atherosclerosis 1988; 69: 145-153.
119. Buring JE, O'Connor GT, Goldhaber SZ, Rosner B, Herbert PN, Blum CB et al. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation 1992; 85: 22-29.
120. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991; 325: 373-381.
121. Renaud SC, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation. the Caerphilly prospective heart disease study. Am J Clin Nutr 1992; 55: 1.012-1.017.
122. Ridker PM, Vaughamm DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994; 272: 929-933.
123. Kluft C, Veenstra J, Schaafsma G, Pikaar NA. Regular moderate wine consumption for five weeks increases plasma activity of the plasminogen activator inhibitor-1 (PAI-1) in healthy young volunteers. Fibrinolysis 1990; 4 (Supl 2): 69-70.
124. Stampfer MJ, Rimm EB, Walsh DC. Comentary: alcohol, the heart, and public policy. Am J Public Health 1993; 83: 801-804.
125. Criqui MH, Cowan LD, Heiss G, Haskell WL, Laskarzewski PM, Chambless LE. Frequency and clustering of non-lipid coronary risk factors in dysliproteinemia. Circulation 1986; 73 (Supl 1): 40-50.
126. Laug WE. Ethyl alcohol enhances plasminogen activator secretion by endothelial cells. JAMA 1983; 250: 272-274.
127. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation human low-density lipoprotein by phenolic substances in red wine. Lancet 1993, 341: 454-457.
128. Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Viticult 1992; 43: 49-52.
129. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum. Lancet 1994; 344: 193-194.
130. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1.103-1.104.
131. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 1993; 265 (Supl H): 774-778.
132. Hoffman RM, Garewal HS. Antioxidants and the prevention of coronary heart disease. Arch Intern Med 1995; 155: 241-244.
133. Morris DL, Krichevsky SB, Davis CE. Serum carotenoids and coronary heart disease: the Lipid Research Clinics Coronary Primary Pevention Trial and Follow-up Study. JAMA 1994; 272: 1.439-1.502.
134. National Cholesterol Education Program. Second report of the Expert Panel of Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 1994; 89: 1.329.
135. Steinberg D. Antioxidant vitamins and coronary heart disease [editorial]. N Engl J Med 1993; 328: 1.487.
136. Serafini M, Ghiselli A, Ferro-Luzzi A. Red wine, tea and antioxidants. Lancet 1994; 344: 626-628.
137. Whitehaed TP, Robinson D, Allaway S, Sym J, Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 1995; 41: 32-35.
138. Lasunción MA, Ortega H, Carrero P, Martínez-Botas J, Álvarez JJ, Gómez-Coronado D. Flavonoides del vino y oxidación de las lipoproteínas plasmáticas. En: Medina FX, editor. La alimentación mediterránes. Historia. cultura, nutrición. Barcelona: Icaria-Antrazyt, 1996; 295-308.
139. Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brien J, Jarnell JWC. Ischaemic heart disease and platelet aggregation. The Caerphilly collaborative heart disease study. Circulation 1991; 83: 38-44.
140. Douste-Blazy P, Riudavets JB, Atveiller D. Facteurs de risque cardiovasculaire dans la population de deux regions couvertes par les registres MONICA-France: Strasbourg et Toulouse. Rev Epideiol Santé Publique 1968; 6: 342-349.
141. De Whaley CV, Rankin SM, Hoult JRS, Jessup W, Leake DS. Flavonoids inhibit the oxidative modification of low density lipoproteins. Biochem Pharmacol 1990; 39: 1.743-1.749.
142. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995; 61: 549-554.
143. Hurtado I, Caldú P, Gonzalo A, Ramón JM, Mínguez S, Fiol C. El contacto del mosto con la piel de la uva durante el proceso de producción del vino blanco incrementa su capacidad antioxidante. Clin Invest Arterioscler 1997; 9: 1-8.
144. Caldú P, Hurtado I, Gonzalo A, Ramón JM, Mínguez S, Fiol C. White wine reduces the susceptibility of low-density lipoprotein to oxidation [carta]. Am J Clin Nutr 1996; 3: 403.
145. Kühnau J. The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976; 24: 117-120.
146. Gugler R, Leschik M, Dengler HJ. Deposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 1975; 9: 229-234.
147. Hacket AM, Griffiths LA, Broillet A, Wermeille M. The metabolism and excretion of (+)-cyanidol-3 in man following oral administration. Xenobiotica 1983; 13: 279-283.
148. Fuhrman B, Aviram M. Reply to Caldú's [carta]. Am J Clin Nutr 1996; 63: 403.
149. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease mortality. The Zutphen elderly study. Lancet 1993; 342: 1.007-1.011.
150. Lasunción MA, Olmos JM, Entrala A, Herrera E. Fenotipos de apo E y niveles de lipoproteínas en la población laboral del Hospital Ramón y Cajal. Clin Invest Arteriosclerosis 1990; 2 (Supl 1): 7.
151. James RW, Boemi M, Giansanti R, Fumelli P, Pometta D. Underexpression of apolipoprotein E4 isoform in an italian population. Atherosclerosis and Thrombosis 1993; 13: 1.456-1.459.
152. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atheroesclerosis. Arteriosclerosis 1988; 8: 1-21.
153. Corder EH, Saunders AM, Strittmatter WJ, Schemechel DE, Gaskell PC, Small GW et al. Gene dose of apoliprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
154. Gregg RE, Brewer HB Jr. The role of apoliprotein E and liprotein receptors in modulating the in vivo metabolism of apoliprotein B-containing liproteins in humans. Clin Chem 1988; 34: B28-B32.
155. Keys A. Coronary heart disease in seven countries. Circulation 1970; 4 (Supl 1): 211.
156. Jackson R, Beaglehole R. Alcohol consumption guidelines: relative safety vs absolute risks and benefits. Lancet 1995; 346: 716.
157. Friedman GD, Klatsky AL. Is alcohol good for your health? N Engl J Med 1993; 329: 1.882-1.883.
158. Garfinkel L, Boffetta P, Stellman SD. Alcohol and breast cancer, a cohort study. Prev Med 1988; 17: 686-689.
159. Meyer F, White E. Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol 1993; 138: 225-236.
160. Andreasson S, Allebeck P, Romelsjo A. Alcohol and mortality among young men: longitudinal study of Swedish conscripts. BMJ 11988; 296: 1.021-1.025.
161. Gaziano JM, Hennekens C. Royal Colleges' advice on alcohol consumption: maintaining existing limits seems justified on current evidence. BMJ 1995; 311: 3-4.